vigabatrin · Pyros Pharms · NDA 217684
Vigafyde
Earliest generic entry, as listed
8 Jun 2043
Blocked by patent: US 12576054.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12576054 | drug product · sets the listed date | 8 Jun 2043 |
| US 12290499 | drug product | 17 Oct 2042 |
| US 12016857 | drug product | 16 Aug 2039 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 217684 · 001 · RLD | solution, oral | 100MG/ML | 8 Jun 2043 |